To further explore PAX2's role in HCC and its clinical-predictive efficacy, we first used a ROC curve to predict the predictive efficacy of PAX2, CCND1, MYC, NEDD4, and CXCL5 expressions for HCC. Here, PAX2 is linked to hepatocellular carcinoma.